SCHEMBL8843269

SCHEMBL8843269

CC(=O)ONCc1ccc2ccccc2n1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.50
▸ HDAC1 Q13547 3/20 0.49
▸ HDAC2 Q92769 3/20 0.49
▸ HDAC8 Q9BY41 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ MEN1 O00255 1/20 0.46
▸ NPC1 O15118 1/20 0.46
▸ RAB9A P51151 1/20 0.46
▸ KMT2A Q03164 1/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ CYSLTR1 Q9Y271 4/20 0.45
▸ GPBAR1 Q8TDU6 3/20 0.45
▸ HDAC6 Q9UBN7 1/20 0.44
▸ ADORA2A P29274 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ CYSLTR2 Q9NS75 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX5 P09917 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8843526 0.98 CYP1A2 (0.49) CYP1A2HDAC1HDAC2HDAC8MAPT
SCHEMBL29858336 0.80 NPSR1 (0.64) CYP1A2HDAC1HDAC2HDAC8MAPT
SCHEMBL19407338 0.80 NPSR1 (0.64) CYP1A2HDAC1HDAC2HDAC8MAPT
SCHEMBL28205113 0.77 HDAC1 (0.57) CYP1A2HDAC1HDAC2HDAC8MEN1
SCHEMBL8843570 0.77 CYP1A2 (0.51) CYP1A2HDAC1HDAC2HDAC8MAPT
SCHEMBL3951224 0.76 GPBAR1 (0.55) CYP1A2MAPTMEN1NPC1RAB9A
SCHEMBL10980763 0.75 CYP1A2 (0.53) CYP1A2MAPTMEN1NPC1RAB9A
SCHEMBL3807364 0.75 NOTUM (0.40) CYP1A2HDAC1HDAC2NPC1RAB9A
SCHEMBL15578063 0.74 HDAC1 (0.61) CYP1A2HDAC1HDAC2HDAC8MAPT
SCHEMBL7832872 0.74 HDAC1 (0.54) CYP1A2HDAC1HDAC2HDAC8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5672615-A MATRIX-DEGRADING METALLOPROTEINASE INHIBITORS NOVARTIS CORPORATION (US) 1997-09-30 — — US disclosed
Send feedback